MedTrace Logo

Fangshan / Family-based Ischemic Stroke Study In China

NCT00534742 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2011-12-14

No results posted yet for this study

Summary

The exact etiology of ischemic stroke remains unclear, because multiple genetic predispositions and environmental risk factors may be involved, and their interactions dictate the complexity. Family-based studies provide unique features in design because of their robustness to population admixture and stratification. The Fangshan / Family-based Ischemic Stroke Study In China (FISSIC) program aims to conduct a genetic pedigree study of ischemic stroke in rural communities of China.

Conditions

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Ministry of Education, China

    collaborator OTHER_GOV

  • Ministry of Science and Technology of the People´s Republic of China

    collaborator OTHER_GOV

  • Peking University

    lead OTHER

Principal Investigators

  • Yonghua Hu, MD · Peking University School of Public Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534742 on ClinicalTrials.gov